CAR T cell therapy is a promising immunological treatment for
Triplet Therapy Slows Refractory Multiple Myeloma
WEDNESDAY, Nov. 18, 2020 — A once-weekly regimen of selinexor,
RNA defects linked to multiple myeloma progression in high risk patients
Multiple myeloma (MM) is the second most common type of